Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
9/27/24 17:10 | 9/26/24 | PKTX | Health | Drug | Pharmaceutical Preparations | Smith Clarence Edward | FL | DOT | P,CEO | 5 | P.dm | 260 | 0.0127 | 0 | 20,500 | 31 | 85,637 | D | ||||||||||||||
10/27/23 17:06 | 10/26/23 | PKTX | Health | Drug | Pharmaceutical Preparations | Guzzetta Michael Richard | OH | O | CFO | 1 | P.d | 0 | 0.0165 | 0 | 20 | 3 | 736 | D |
D | Derivative transaction in filing (usually option exercise) |
M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
A | Amended filing |
E | Error detected in filing |
S - Sale | Sale of securities on an exchange or to another person |
S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
P - Purchase | Purchase of securities on an exchange or from another person |